China's healthcare shares dip as govt launches another round of centralised procurement

China Health

26/01/2022 03:19

** Healthcare shares in mainland and Hong Kong markets fall
as the government steps up centralised pharmaceutical
procurement to lower medical costs for patients
    ** Local media 21st Century Business Herald reported http://www.21jingji.com/article/20220126/08bf17302f5666f2ec07354a1f616ab7.html
 on Wednesday that a seventh round of centralised procurement
has been launched
    ** The State Council said earlier this month that more drugs
for common diseases and illnesses, and more high-value medical
items should be included in the centralised bulk-buying
programme, state media reported http://www.xinhuanet.com/english/20220111/6ad5e5ce54ce47c9a575bbc1f9405345/c.html
  
    ** The CSI300 Health Care index  .CSI300HC  falls 1.11%
versus a 0.42% gain in the blue-chip index  .CSI300 
    ** The Hang Seng Health Care index  .HSHCI  falls 2.2%,
while the broader Hang Seng  .HSI  rises 0.46% 
    

 (Reporting by Andrew Galbraith and Luoyan Liu)
 ((Andrew.Galbraith@tr.com))